Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy
- 1 December 1990
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 150 (12) , 2545-2548
- https://doi.org/10.1001/archinte.150.12.2545
Abstract
Research from JAMA Internal Medicine — Determinants of Vertebral Mineral Density in Patients Receiving Long-term Glucocorticoid TherapyThis publication has 16 references indexed in Scilit:
- Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica.BMJ, 1986
- The assessment of intestinal calcium absorption using stable strontiumCalcified Tissue International, 1986
- BONE LOSS IN RHEUMATOID ARTHRITIS AND PRIMARY GENERALIZED OSTEOARTHROSIS: EFFECTS OF CORTICOSTEROIDS, SUPPRESSIVE ANTIRHEUMAT1C DRUGS AND CALCIUM SUPPLEMENTSRheumatology, 1986
- Calcium supplements in the prevention of steroid-induced osteoporosisThe American Journal of Clinical Nutrition, 1986
- Low Serum Osteocalcin Levels in Glucocorticoid-Treated Asthmatics*Journal of Clinical Endocrinology & Metabolism, 1986
- Mineral loss in cortical and trabecular bone during high-dose prednisone treatmentCalcified Tissue International, 1984
- Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapyMetabolism, 1983
- Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomographyEuropean Journal of Clinical Pharmacology, 1983
- Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.Journal of Clinical Investigation, 1979
- CORTICOSTEROID-INDUCED OSTEOPENIA1978